Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    crohn's celgene
Show Display Options
Rank Status Study
1 Not yet recruiting A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
2 Completed A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: Human Placenta-Derived Cells PDA001 Intravenous Infusion
3 Active, not recruiting A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
Condition: Crohns Disease
Interventions: Biological: PDA001;   Drug: Vehicle Controlled Placebo
4 Completed Thalidomide in Pediatric Inflammatory Bowel Diseases.
Conditions: Inflammatory Bowel Diseases;   Crohn's Disease;   Ulcerative Colitis
Interventions: Drug: Thalidomide;   Drug: placebo
5 Completed A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CC-5013

Indicates status has not been verified in more than two years